Predictive scores for major bleeding after coronary artery bypass surgery in low operative risk patients.


Journal

The Journal of cardiovascular surgery
ISSN: 1827-191X
Titre abrégé: J Cardiovasc Surg (Torino)
Pays: Italy
ID NLM: 0066127

Informations de publication

Date de publication:
Apr 2020
Historique:
pubmed: 16 1 2020
medline: 9 4 2020
entrez: 16 1 2020
Statut: ppublish

Résumé

Cardiac surgery is associated with perioperative bleeding and carries high risk of allogeneic blood transfusion. Recently new scores for prediction of severe bleeding have been developed. This study aims to compare the WILL-BLEED, CRUSADE, PAPWORTH, TRUST, TRACK and ACTION scores in predicting major bleeding after CABG in patients with low estimated operative risk. A multicenter observational study included 1391 patients who underwent isolated CABG from July 2015 to January 2018. We tested the hypothesis that the WILL-BLEED score, specifically designed for CABG, would perform at least as well as the CRUSADE, PAPWORTH, TRUST, TRACK and ACTION scores in predicting postoperative major bleeding in low operative risk patients. The primary endpoint was the performance of known bleeding risk scores after CABG. The secondary endpoint was the evaluation of in-hospital mortality. Mean age was 68.2±9.4 years and median Euroscore II value was 1.69% (IQR 1.15-2.81%). Mean blood losses in the first 12 postoperative hours was 339.75 mL. Seventy-three (5.2%) subjects underwent administration of blood products. The rate of severe-massive bleeding according to UDPB grades 3-4 was 1.5%. WILL-BLEED, TRUST, TRACK and ACTION scores were significantly associated with severe postoperative bleeding. WILL-BLEED presented the best c-index (AUC: 0.658; 95% CI: 0.600,0.716). Reclassification analysis showed a worsening in sensitivity and significant negative reclassification of CRUSADE, PAPWORTH, TRACK and ACTION scores when compared with WILL-BEED. The combination of WILL-BLEED and TRUST scores improved the prediction ability (AUC: 0.673; 95% CI: 0.615-0.732). Overall in-hospital mortality was 1.65%. Early mortality in patients with severe versus no-severe bleeding was found to be 11.8% vs. 1.0% Severe bleeding (OR: 13.26; P value<0.001) was found to be significantly associated with early mortality. Severe bleeding after CABG is a harmful event associated with adverse outcomes. WILL-BLEED Score has the better performance in predicting severe-massive bleeding after CABG. The TRUST Score, although suboptimal, represents a valuable alternative in this setting.

Sections du résumé

BACKGROUND BACKGROUND
Cardiac surgery is associated with perioperative bleeding and carries high risk of allogeneic blood transfusion. Recently new scores for prediction of severe bleeding have been developed. This study aims to compare the WILL-BLEED, CRUSADE, PAPWORTH, TRUST, TRACK and ACTION scores in predicting major bleeding after CABG in patients with low estimated operative risk.
METHODS METHODS
A multicenter observational study included 1391 patients who underwent isolated CABG from July 2015 to January 2018. We tested the hypothesis that the WILL-BLEED score, specifically designed for CABG, would perform at least as well as the CRUSADE, PAPWORTH, TRUST, TRACK and ACTION scores in predicting postoperative major bleeding in low operative risk patients. The primary endpoint was the performance of known bleeding risk scores after CABG. The secondary endpoint was the evaluation of in-hospital mortality.
RESULTS RESULTS
Mean age was 68.2±9.4 years and median Euroscore II value was 1.69% (IQR 1.15-2.81%). Mean blood losses in the first 12 postoperative hours was 339.75 mL. Seventy-three (5.2%) subjects underwent administration of blood products. The rate of severe-massive bleeding according to UDPB grades 3-4 was 1.5%. WILL-BLEED, TRUST, TRACK and ACTION scores were significantly associated with severe postoperative bleeding. WILL-BLEED presented the best c-index (AUC: 0.658; 95% CI: 0.600,0.716). Reclassification analysis showed a worsening in sensitivity and significant negative reclassification of CRUSADE, PAPWORTH, TRACK and ACTION scores when compared with WILL-BEED. The combination of WILL-BLEED and TRUST scores improved the prediction ability (AUC: 0.673; 95% CI: 0.615-0.732). Overall in-hospital mortality was 1.65%. Early mortality in patients with severe versus no-severe bleeding was found to be 11.8% vs. 1.0% Severe bleeding (OR: 13.26; P value<0.001) was found to be significantly associated with early mortality.
CONCLUSIONS CONCLUSIONS
Severe bleeding after CABG is a harmful event associated with adverse outcomes. WILL-BLEED Score has the better performance in predicting severe-massive bleeding after CABG. The TRUST Score, although suboptimal, represents a valuable alternative in this setting.

Identifiants

pubmed: 31937080
pii: S0021-9509.20.11048-6
doi: 10.23736/S0021-9509.20.11048-6
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

234-242

Auteurs

Antonio Salsano (A)

Division of Cardiac Surgery, San Martino University Hospital IRCCS, University of Genoa, Genoa, Italy - ant.salsano@gmail.com.

Carmelo Dominici (C)

Division of Cardiovascular Surgery, Campus Bio-Medico University, Rome, Italy.

Antonio Nenna (A)

Division of Cardiovascular Surgery, Campus Bio-Medico University, Rome, Italy.

Guido M Olivieri (GM)

Division of Cardiac Surgery, San Martino University Hospital IRCCS, University of Genoa, Genoa, Italy.

Ambra Miette (A)

Division of Cardiac Surgery, San Martino University Hospital IRCCS, University of Genoa, Genoa, Italy.

Raffaele Barbato (R)

Division of Cardiovascular Surgery, Campus Bio-Medico University, Rome, Italy.

Elena Sportelli (E)

Division of Cardiac Surgery, San Martino University Hospital IRCCS, University of Genoa, Genoa, Italy.

Roberto Natali (R)

Division of Cardiac Surgery, San Martino University Hospital IRCCS, University of Genoa, Genoa, Italy.

Francesco Maestri (F)

Division of Cardiac Surgery, San Martino University Hospital IRCCS, University of Genoa, Genoa, Italy.

Massimo Chello (M)

Division of Cardiovascular Surgery, Campus Bio-Medico University, Rome, Italy.

Giovanni Mariscalco (G)

Division of Cardiac Surgery, San Martino University Hospital IRCCS, University of Genoa, Genoa, Italy.
Department of Cardiac Surgery, Glenfield Hospital, University Hospitals of Leicester, Leicester, UK.

Francesco Santini (F)

Division of Cardiac Surgery, San Martino University Hospital IRCCS, University of Genoa, Genoa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH